Effects of In Vitro and In Vivo Exposure to Doxorubicin (Adriamycin) on Caffeine-Induced Ca2+ Release from Sarcoplasmic Reticulum and Contractile Protein Function in ‘Chemically-Skinned’ Rabbit Ventricular Trabeculae-Reference-Cited by-同舟云学术

Effects of In Vitro and In Vivo Exposure to Doxorubicin (Adriamycin) on Caffeine-Induced Ca2+ Release from Sarcoplasmic Reticulum and Contractile Protein Function in ‘Chemically-Skinned’ Rabbit Ventricular Trabeculae

Published:1998 Issue:4 Volume:76 Page:405-413
ISSN:0021-5198
Container-title:Japanese Journal of Pharmacology
language:en
Short-container-title:Japanese Journal of Pharmacology

Author:

Takahashi Shun-suke,Denvir Martin A.,Harder Lisbet,Miller David J.,Cobbe Stuart M.,Kawakami Midori,MacFarlane Niall G.,Okabe Eiichiro

Publisher

Elsevier BV

Subject

Pharmacology

Link

https://www.jstage.jst.go.jp/article/jjp/76/4/76_4_405/_pdf

Reference29 articles.

1. Acute arrhythmogenicity of doxorubicin administration;Steinberg;Cancer,1987

2. Sub-cellular effects of doxorubicin in the heart: a concise review;Singal;J Mol Cell Cardiol,1987

3. Doxorubicin cardiomyopathy is associated with a reduction in the calcium release channel of the sarcoplasmic reticulum in a chronic rabbit model;Dodd;J Clin Invest,1993

4. Excitation-Contraction Coupling and Cardiac Contractile Force;Bers,1991

5. The anthracycline antibiotics depress left ventricular contractility: a clinical fact or a laboratory fancy?;Applefielg;Int J Cardiol,1984

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology;International Journal of Molecular Sciences;2022-09-13

2. The Effects of Repeat-Dose Doxorubicin on Cardiovascular Functional Endpoints and Biomarkers in the Telemetry-Equipped Cynomolgus Monkey;Frontiers in Cardiovascular Medicine;2021-02-23

3. Anthracycline-Related Heart Failure: Certain Knowledge and Open Questions;Current Heart Failure Reports;2020-09-23

4. Transcriptomic profiling reveals p53 as a key regulator of doxorubicin-induced cardiotoxicity;Cell Death Discovery;2019-06-12

5. CaMKII activation participates in doxorubicin cardiotoxicity and is attenuated by moderate GRP78 overexpression;PLOS ONE;2019-04-29